Newbrook Consulting ltd


Early Stage Capital

Register Interest

New Zealand law typically requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer, where: a. Investments of $750,000 or more: the amount invested upfront by the investor (plus any other investments the investor has already made in the financial products) is $750,000 or more. Investments of this kind (i.e., $750,000 or more) are not suitable for retail investors; and b. Other wholesale investors: other wholesale investor categories apply to you under Schedule 1 of the Financial Markets Conduct Act 2013. As a result of these exclusions, you may not receive a complete and balanced set of information. You will also have fewer other legal protections for these investments. Ask questions, read all documents carefully, and seek independent financial advice before committing yourself

Transaction Size
NZD 1,500,000.00
Share Price
Minimum Investment
NZD 50,000.00
Issue Type
Early Stage Capital
Health Care

The opportunity exists for wholesale investors to express an interest to invest in Plantonin.

Plantonin specialises in the development of scientifically researched high quality nootropics, supplements, and creams for the North American market. Plantonin has internationally protected IP and trademarks allowing scale and sources, where it can, scientifically researched premium New Zealand sustainable ingredients that global consumers trust and that also have a point of difference from others within the market. Following extensive research, Plantonin has developed a range of unique nootropics, supplements, and creams for the North American market. It's unique formulations have been formulated by some of New Zealand’s best biochemists, scientists, naturopaths, and medical herbalists. Currently, Plantonin exports mostly to the North American market selling to 145 million prime customers on the Amazon platform. Sales to date have been promising with strong customer feedback and a pathway to significant growth achievable with the right investment.

The future opportunities are significant with a global market work of $295.5bn being $67bn in the United States alone. The Plantonin executive team have identified other key global markets such as Canada and Asia and work closely with NZTE. Plantonin is seeking capital to scale the business and is offering an opportunity to invest in an exciting global industry, from New Zealand. Plantonin is forecasting to achieve revenues of $9.4M by FTY24 with an EBITDA of $2M just through its current market channels, returning a consistent yield to shareholders.

On offer is the opportunity to invest into Plantonin through ordinary shares priced at $0.78 per share with a minimum investment of $50,000 against a pre-money valuation of $7.8M.

Please review the information memorandum, found in the Documents tab or Register Interest.

Newbrook Plantonin IM - Syndex
August 20, 2021

Newbrook Consulting ltd

Join our Issuer newsletter

Our quarterly Issuer newsletter is for partners, businesses and anyone interested in what we’re up to, platform updates and market commentary. To sign up to the Investor newsletter for marketplace offers click here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.